Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients

Biological Psychiatry

Volumn 52, Issue 9, 2002, Pages 863-873

  Mackeprang, Torben ^a   Kristiansen, Klaus T ^a   Glenthoj, Birte Y ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

Antipsychotics; Drug na ve; PPI; Schizophrenia; Stable vulnerability indicator; Startle response

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE; ZUCLOPENTHIXOL;

ARTICLE; BRAIN DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MALE; PREPULSE INHIBITION; PRIORITY JOURNAL; SCHIZOPHRENIA; STARTLE REFLEX; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; CLOPENTHIXOL; FEMALE; FOLLOW-UP STUDIES; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; LONGITUDINAL STUDIES; MALE; NEURAL INHIBITION; RISPERIDONE; SCHIZOPHRENIA; STARTLE REACTION;

EID: 0036838560     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01409-9     Document Type: Article

References (84)

1. Bakshi V.P., Geyer M.A. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology (Berl). 122:(2):1995;198-201.
2. Bakshi V.P., Geyer M.A. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. J Pharmacol Exp Ther. 283:(2):1997;666-674.
3. Bakshi V.P., Geyer M.A. Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats. Neuroscience. 92:(1):1999;113-121.
4. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther. 271:1994;787-794.
5. Bakshi V.P., Tricklebank M., Neijt H.C., Lehmann-Masten V., Geyer M.A. Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats. J Pharmacol Exp Ther. 288:(2):1999;643-652.
6. Bast T., Zhang W., Feldon J., White I.M. Effects of MK801 and neuroleptics on prepulse inhibition Re-examination in two strains of rats . Pharmacol Biochem Behav. 67:(3):2000;647-658.
7. Bille A (1999): Undersøgelser af hjernens dopaminerge og serontonerge transmissionssystemer: Implikationer for udvikling af extrapyramidale bivirkninger (Studies on the brain dopaminergic and serotonergic transmitter systems: Implications for development of extrapyramidal side-effects). Thesis in Danish. FADL Publishing House.
8. Bolino F., Manna V., Di Cicco L., Di M.V., Daneluzzo E., Rossi A., Casacchia M. Startle reflex habituation in functional psychoses A controlled study. Neurosci Lett. 145:(2):1992;126-128.
9. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:(4):1978;339-343.
10. Braff D.L. Information processing and attention dysfunctions in schizophrenia. Schizophr Bull. 19:(2):1993;233-259.
11. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia Human and animal model studies . Arch Gen Psychiatry. 47:(2):1990;181-188.
12. Braff D.L., Geyer M.A., Light G.A., Sprock J., Perry W., Cadenhead K.S., Swerdlow N.R. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res. 49:(1-2):2001;171-178.
13. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle Normal subjects, patient groups, and pharmacological studies . Psychopharmacology (Berl). 156:(2-3):2001;234-258.
14. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 49:(3):1992;206-215.
15. Braff D.L., Swerdlow N.R., Geyer M.A. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry. 156:(4):1999;596-602.
16. Cadenhead K.S., Geyer M.A., Braff D.L. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry. 150:(12):1993;1862-1867.
17. Cadenhead K.S., Light G.A., Geyer M.A., Braff D.L. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry. 157:(1):2000;55-59.
18. Cadenhead K.S., Swerdlow N.R., Shafer K.M., Diaz M., Braff D.L. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder Evidence of inhibitory deficits . Am J Psychiatry. 157:(10):2000;1660-1668.
19. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1:(3):1988;179-186.
20. Davis M. Mescaline Excitatory effects on acoustic startle are blocked by serotonin2 antagonists . Psychopharmacology (Berl). 93:(3):1987;286-291.
21. Davis M., Kehne J.H., Commissaris R.L. Antagonism of apomorphine-enhanced startle by alpha 1-adrenergic antagonists. Eur J Pharmacol. 108:(3):1985;233-241.
22. Dawson M.E., Hazlett E.A., Filion D.L., Nuechterlein K.H., Schell A.M. Attention and schizophrenia Impaired modulation of the startle reflex . J Abnorm Psychol. 102:(4):1993;633-641.
23. Depoortere R., Perrault G., Sanger D.J. Potentiation of prepulse inhibition of the startle reflex in rats Pharmacological evaluation of the procedure as a model for detecting antipsychotic activity . Psychopharmacology (Berl). 132:(4):1997;366-374.
24. Ebert U., Koch M. Glutamate receptors mediate acoustic input to the reticular brain stem. Neuroreport. 3:(5):1992;429-432.
25. Feifel D., Priebe K. The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating. Psychopharmacology (Berl). 146:(2):1999;175-179.
26. Filion D.L., Dawson M.E., Schell A.M. Modification of the acoustic startle-reflex eyeblink A tool for investigating early and late attentional processes . Biol Psychol. 35:(3):1993;185-200.
27. Geyer M.A., Braff D.L. Habituation of the Blink reflex in normals and schizophrenic patients. Psychophysiology. 19:(1):1982;1-6.
28. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia A decade in review . Psychopharmacology (Berl). 156:(2-3):2001;117-154.
29. Geyer M.A., Swerdlow N.R., Mansbach R.S., Braff D.L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull. 25:(3):1990;485-498.
30. Geyer M.A., Tapson G.S. Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors. Neuropsychopharmacology. 1:(2):1988;135-147.
31. Glenthoj B. Persistent vacuous chewing in rats following neuroleptic treatment Relationship to dopaminergic and cholinergic function . Psychopharmacology. 113:1993;157-166.
32. Glenthoj B., Hemmingsen R., Allerup P., Barry D., Bruhn T., Bolwig T.G. Electrical kindling of rats treated discontinuously or continuously with haloperidol. Eur J Pharmcol. 236:1993;401-409.
33. Glenthoj B., Hemmingsen R., Allerup P., Bolwig T.G. Intermittent versus continuous neuroleptic treatment A rat model . Eur J Pharmacol. 190:1990;275-286.
34. Glenthoj B., Mogensen J., Holm S., Hemmingsen R. Electrical sensitization of the meso-limbic dopaminergic system in rats A pathogenetic model for schizophrenia . Brain Research. 619:1993;39-54.
35. Glenthoj B.Y. The brain dopaminergic system Pharmacological, behavioural and electrophysiological studies . Danish Medical Bulletin. 42:(1):1995;1-21.
36. Glenthoj BY, Gerlach J, Licht R, Gulmann N, Jorgensen OS. (Eds.) (1998b): Guidelines for treatment with antipsychotics. (Danish Psychiatric Association. The Committee on Biological Treatments in Psychiatry) (in danish) Journal of the Danish Medical Association. Klaringsrapport nr. 5.
37. Glenthoj B.Y., Mackeprang T., Bille A.E., Hemmingsen R. Transmitter dysfunction in schizophrenia Implications for cognitive functioning and treatment . Int J of Psychiatry in Clin Pract. 2:1998;21-32.
38. Graham FK (1975): Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psycholphysiology 12(3):238-248.
39. Green M.F., Nuechterlein K.H. Should schizophrenia be treated as a neurocognitive disorder? Schizophr Bull. 25:(2):1999;309-319.
40. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry. 32:(10):1992;939-943.
41. Hamm A.O., Weike A.I., Schupp H.T. The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients Current status and future issues . Psychopharmacology (Berl). 156:(2-3):2001;259-265.
42. Hazlett E.A., Buchsbaum M.S., Haznedar M.M., Singer M.B., Germans M.K., Schnur D.B. Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. Psychophysiology. 35:(2):1998;186-198.
43. Hazlett E.A., Buchsbaum M.S., Tang C.Y., Fleischman M.B., Wei T., Byne W. Thalamic activation during an attention-to-prepulse startle modification paradigm A functional MRI study . Biol Psychiatry. 50:(4):2001;281-291.
44. Hoffman D.C., Donovan H., Cassella J.V. The effects of haloperidol and clozapine on the disruption of sensory motor gating induced by the non-competitive glutamate antagonist MK-801. Psychopharmacology (Berl). 111:1993;339-344.
45. Javitt D.C., Lindsley R.W. Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque. Psychopharmacology (Berl). 156:(2-3):2001;165-168.
46. Johansson C., Jackson D.M., Svensson L. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced distuption of prepulse inhibition in the rat. Psychopharmacology (Berl). 116:(4):1994;437-442.
47. Johansson C., Jackson D.M., Zhang J., Svensson L. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating Effects of antipsychotics and other agents in rats . Pharmacol Biochem Behav. 52:(4):1995;649-654.
48. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizoph Bull. 13:(2):1987;261-276.
49. Krase W., Koch M., Schnitzler H.U. Glutamate antagonists in the reticular formation reduce the acoustic startle response. Neuroreport. 4:(1):1993;13-16.
50. Kumari V., Soni W., Mathew V.M., Sharma T. Prepulse inhibition of the startle response in men with schizophrenia Effects of age of onset of illness, symptoms, and medication . Arch Gen Psychiatry. 57:(6):2000;609-614.
51. Kumari V., Soni W., Sharma T. Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry. 156:(7):1999;1046-1051.
52. Lamont E.W., Kokkinidis L. Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm. Brain Res. 795:(1-2):1998;128-136.
53. Mansbach R.S., Carver J., Zorn S.H. Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone. Pharmacol Biochem Behav. 69:(3-4):2001;535-542.
54. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl). 94:(4):1988;507-514.
55. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. Br J Med Psychol. 34:1961;102-116.
56. Meloni E.G., Davis M. Enhancement of the acoustic startle response in rats by the dopamine D1 receptor agonist SKF 82958. Psychopharmacology (Berl). 144:(4):1999;373-380.
57. Nanry K.P., Tilson H.A. The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats. Psychopharmacology (Berl). 97:(4):1989;507-513.
58. Nuechterlein K.H., Dawson M.E. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull. 10:(2):1984;300-312.
59. Parwani A., Duncan E.J., Bartlett E., Madonick S.H., Efferen T.R., Rajan R. Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry. 47:(7):2000;662-669.
60. 7 receptor antagonist SB-258741 in animal models for schizophrenia. Pharmaco Biochem Behav, in press.
61. Ralph R.J., Paulus M.P., Fumagalli F., Caron M.G., Geyer M.A. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice Differential effects of D1 and D2 receptor antagonists . J Neurosci. 21:(1):2001;305-313.
62. Spiera R.F., Davis M. Excitatory amino acid antagonists depress acoustic startle after infusion into the ventral nucleus of the lateral lemniscus or paralemniscal zone. Brain Res. 445:(1):1988;130-136.
63. Swerdlow N.R., Bakshi V., Geyer M.A. Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther. 279:1996;1290-1299.
64. Swerdlow N.R., Bakshi V., Waikar M., Taaid N., Geyer M.A. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats. Psychopharmacology (Berl). 140:(1):1998;75-80.
65. Swerdlow N.R., Braff D.L., Masten V.L., Geyer M.A. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berl). 101:(3):1990;414-420.
66. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry. 51:(2):1994;139-154.
67. Swerdlow N.R., Geyer M.A. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav. 44:(3):1993;741-744.
68. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat Current knowledge and future challenges . Psychopharmacology (Berl). 156:(2-3):2001;194-215.
69. Swerdlow N.R., Geyer M.A., Hartman P.L., Sprock J., Auerbach P.P., Cadenhead K. Sex differences in sensorimotor gating of the human startle reflex All smoke? Psychopharmacology (Berl). 146:(2):1999;228-232.
70. Swerdlow N.R., Hartman P.L., Auerbach P.P. Changes in sensorimotor inhibition across the menstrual cycle Implications for neuropsychiatric disorders . Biol Psychiatry. 41:(4):1997;452-460.
71. Swerdlow N.R., Mansbach R.S., Geyer M.A., Pulvirenti L., Koob G.F., Braff D.L. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology (Berl). 100:(3):1990;413-416.
72. Swerdlow N.R., Zisook D., Taaid N. Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats Similarities to clozapine . Psychopharmacology (Berl). 114:(4):1994;675-678.
73. Varty G.B., Bakshi V.P., Geyer M.A. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology. 20:1999;311-321.
74. Varty G.B., Higgins G.A. Examination of drug-induced and isolation-induced disruption of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology (Berl). 122:1995;15-26.
75. 2 receptor antagonist ketanserin. Eur J Pharmacol. 287:1995;201-205.
76. Venables P. The effect of auditory and visual stimulation on skin potential responses of schizophrenics. Brain. 83:1960;77-92.
77. Wan F.J., Geyer M.A., Swerdlow N.R. Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharmacology (Berl). 120:(4):1995;433-441.
78. Wan F.J., Taaid N., Swerdlow N.R. Do D1/D2 interactions regulate prepulse inhibition in rats? Neuropsychopharmacology. 14:(4):1996;265-274.
79. Weike A.I., Bauer U., Hamm A.O. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry. 47:(1):2000;61-70.
80. Wiley J.L. Clozapine's effects on phencyclidine-induced disruption of prepulse inhibition of the acoustic startle response. Pharmacol Biochem Behav. 49:1994;1025-1028.
81. World Health Organization (1993): The ICD-10 classification of mental and behavioral disorders. Diagnostic criteria for research.
82. World Health Organization (1994): Schedules for clinical assessment in neuropsychiatry.
83. Yamada S.I., Harano M., Annoh N., Nakamura K., Tanaka M. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the startle in rats. Biol Psychiatry. 46:1999;832-838.
84. Zhang J., Forkstam C., Engel J.A., Svensson L. Role of dopamine in prepulse inhibition of acoustic startle. Psychopharmacology (Berl). 149:(2):2000;181-188.